A clinician's reference guide for the management of atopic dermatitis in Asians
10.5415/apallergy.2018.8.e41
- Author:
Steven CHOW
1
;
Chew Swee SEOW
;
Maria Victoria DIZON
;
Kiran GODSE
;
Henry FOONG
;
Vicheth CHAN
;
Tran Hau KHANG
;
Leihong XIANG
;
Syarief HIDAYAT
;
M Yulianto LISTIAWAN
;
Danang TRIWAHYUDI
;
Srie Prihianti GONDOKARYONO
;
Endang SUTEDJA
;
Inne Arline DIANA
;
Oki SUWARSA
;
Hartati Purbo DHARMADJI
;
Agnes Sri SISWATI
;
Retno DANARTI
;
Retno SOEBARYO
;
Windy Keumala BUDIANTI
;
Author Information
1. Pantai Hospital, Kuala Lumpur, Malaysia. drstevenchow@gmail.com
- Publication Type:Original Article
- Keywords:
Asians;
Atopic dermatitis;
Eczema;
Atopy;
Dermatology
- MeSH:
Adrenal Cortex Hormones;
Asia;
Asian Continental Ancestry Group;
Atrophy;
Calcineurin Inhibitors;
Consensus;
Dermatitis, Atopic;
Dermatology;
Eczema;
Humans;
Indonesia;
Phenotype;
Phototherapy;
Skin;
Skin Care;
Steroids;
Venereology
- From:
Asia Pacific Allergy
2018;8(4):e41-
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Atopic dermatitis (AD) is a common skin condition among Asians. Recent studies have shown that Asian AD has a unique clinical and immunologic phenotype compared with European/American AD. OBJECTIVE: The Asian Academy of Dermatology and Venereology Expert Panel on Atopic Dermatitis developed this reference guide to provide a holistic and evidence-based approach in managing AD among Asians. METHODS: Electronic searches were performed to retrieve relevant systematic reviews and guidelines on AD. Recommendations were appraised for level of evidence and strength of recommendation based on the U.K. National Institute for Health and Care Excellence and Scottish Intercollegiate Guidelines Network guidelines. These practice points were based on the consensus recommendations discussed during the Asia Pacific Meeting of Experts in Dermatology held in Bali, Indonesia in October 2016 and April 2017. RESULTS: The Expert Panel recommends an approach to treatment based on disease severity. The use of moisturizers is recommended across all levels of AD severity, while topical steroids are recommended only for flares not controlled by conventional skin care and moisturizers. Causes of waning efficacy must be explored before using topical corticosteroids of higher potency. Topical calcineurin inhibitors are recommended for patients who have become recalcitrant to steroid, in chronic uninterrupted use, and when there is steroid atrophy, or when there is a need to treat sensitive areas and pediatric patients. Systemic steroids have a limited role in AD treatment and should be avoided if possible. Educational programs that allow a patient-centered approach in AD management are recommended as an adjunct to conventional therapies. Recommendations on the use of phototherapy, systemic drugs, and emerging treatments are also included. CONCLUSION: The management of AD among Asians requires a holistic approach, integrating evidence-based treatments while considering accessibility and cultural acceptability.
